A limited form of granulomatosis with polyangiitis in an ulcerative colitis patient receiving sulfasalazine

References

1. 1.↵
   1. Mintz R,
   2. Feller ER,
   3. Bahr RL,
   4. Shah SA.

   Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 135–139.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Isse N,
   2. Nagamatsu Y,
   3. Yoshimatsu N,
   4. Obata T,
   5. Takahara N.

   Granulomatosis with polyangiitis presenting as an orbital inflammatory pseudo tumor: a case report. J Med case rep 2013; 7: 110.

   OpenUrl
3. 3.↵
   1. Kasuga A,
   2. Mandai Y,
   3. Katsuno T,
   4. Sato T,
   5. Yamaguchi T,
   6. Yokosuka O.

   Pulmonary complications resembling Wegener’s granulomatosis in ulcerative colitis with elevated proteinase-3 anti-neutrophil cytoplasmic antibody. Intern Med 2008; 47: 1211–1214.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Fayaz M,
   2. Sultan A,
   3. Nawaz M,
   4. Sultan N.

   Mesalazine-induced eosinophilic variant of Wegener’s granulomatosis in an ulcerative colitis patient. J Ayub Med Coll Abbottabad 2009; 21: 171–173.

   OpenUrlPubMed
5. 5.↵
   1. Miura N,
   2. Aoyama R,
   3. Kitagawa W,
   4. Yamada H,
   5. Nishikawa K,
   6. Imai H.

   Proteinase 3-antineutrophil cytoplasmic antibody-(PR3-ANCA) positive necrotizing glomerulonephritis after restarting sulphasalazine treatment. Clin Nephrol 2009; 71:74–79.

   OpenUrlPubMed
6. 6.↵
   1. Denissen NH,
   2. Peters JG,
   3. Masereeuw R,
   4. Barrera P.

   Can sulfasalazine therapy induce or exacerbate Wegener’s granulomatosis? Scand J Rheumatol 2008; 37: 72–74.

   OpenUrlPubMed
7. 7.↵
   1. Yano S,
   2. Kobayashi K,
   3. Kato K,
   4. Nishimura K.

   A limited form of Wegener’s granulomatosis with bronchiolitis obliterans organizing pneumonitis-like variant in an ulcerative colitis patient. Intern Med 2002; 41: 1013–1015.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Zachary S Wallace

   , Eli M Miloslevsky. Management of ANCA associated vasculitis. BMJ 2020; 368: 421.

   OpenUrl
9. 9.↵
   1. Seo P,
   2. Specks U,
   3. Keogh KA.

   Efficacy of rituximab in limited Wegener’s granulomatosis with refractory granulomatous manifestations. J Rheumatol 2020; 35: 2017–2023.

   OpenUrl